Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.
about
Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developmentsFibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular CarcinomaGenome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.Downstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma.The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.Prognostic factors in fibrolamellar hepatocellular carcinoma in young peoplePutative effectors for prognosis in lung adenocarcinoma are ethnic and gender specificTranscriptomic characterization of fibrolamellar hepatocellular carcinoma.Fibrolamellar hepatocellular carcinoma: current clinical perspectives.Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.Liver transplantation for fibrolamellar hepatocellular carcinoma: A national perspective.Prognosis of Fibrolamellar Carcinoma Compared to Non-cirrhotic Conventional Hepatocellular Carcinoma.DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.Intracranial metastasis in fibrolamellar hepatocellular carcinoma.Non coding RNA analysis in fibrolamellar hepatocellular carcinoma.Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI.mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
P2860
Q26746583-D2BAADAC-83BF-46F8-912E-1512E278A317Q28072292-43A0B9E3-C5BA-4323-A141-8651CA8F2F14Q33652971-0CDD4941-D469-4715-B8EF-0A315B10E2E2Q33814048-7D71C307-EB9F-4E93-9A1E-BAE0CB1C8808Q34458870-4616E32A-20B5-4D9B-86E7-C265FEB1EC44Q36023427-C29A3EEA-F1D2-436A-BC0C-9DB8B29F067BQ36260566-F947D6A8-31B2-4A0E-8E77-1FC7F2BB1766Q36268536-EE88F221-F810-4087-BA9C-751EC340E1C1Q37031777-434DDFC8-2DD5-4DCD-8E81-9DB498D390BEQ38774463-4BC74A9C-2D9B-477B-BCA6-8FAF762D4240Q38901483-05DC5364-E9F9-43EB-A384-29CB5EFD5D5DQ39160124-C12D7973-04E4-42C3-B00B-540FAFD259EDQ46545465-66FD37ED-9DEB-4DE1-85D0-E02D1AB08125Q47377422-159BD117-F476-40FA-9A95-20E2A199B540Q47891035-BF9052FF-141C-4997-8E43-44531D0C07CDQ52657106-052ACADD-A48E-49DF-84E9-20D2599E63CBQ54264769-7C7502D0-F219-4510-95C6-76F89174752CQ54345071-A3901BFB-7128-40AE-89F1-3D51F895BC2E
P2860
Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic indicators and trea ...... llar hepatocellular carcinoma.
@en
Prognostic indicators and trea ...... llar hepatocellular carcinoma.
@nl
type
label
Prognostic indicators and trea ...... llar hepatocellular carcinoma.
@en
Prognostic indicators and trea ...... llar hepatocellular carcinoma.
@nl
prefLabel
Prognostic indicators and trea ...... llar hepatocellular carcinoma.
@en
Prognostic indicators and trea ...... llar hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Prognostic indicators and trea ...... llar hepatocellular carcinoma.
@en
P2093
Ahmed O Kaseb
Ajay Nooka
Hesham M Hassabo
Ibrahim Halil Sahin
Ishwaria M Subbiah
James L Abbruzzese
Manal M Hassan
Mohamed Shama
Steven Curley
Thomas Aloia
P2860
P304
P356
10.1159/000354698
P577
2013-09-19T00:00:00Z